Virechana followed by shaman dravya,modern drug Omeprazole and lifestyle manangement in Amlapitta

Standard controlled clinico-comparative study of Virechana followed by Shamana with lifestyle management in Amlapitta(GERD) - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/09/073812

Enrollment

Registered

2024-09-12

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Classical symptoms of Amlapitta as described in Ayurvedic texts viz. Hridkantha Daah (burning sensation in epigastric region), Aruchi (loss of appetite). Utklesha (Nausea), Tiktaamla Udgaar (Acid regurgitation), Udar Adhmana (Flatulence), Avipaaka (Indigestion). 2. GERD (Hyperacidity) without any complications. 3. Patients between age group 16-60 years will be selected for the study. 4. Patients who are fit for Virechana Karma. 5. Patients who are willing to give written consent.

Exclusion criteria

Exclusion criteria: 1.Patients suffering from severe diseases like uncontrolled diabetes, renal disease, liver disease and cardiovascular disease (uncontrolled HTN). 2. Patients who are unfit for Virechana Karma. 3. Lactating and pregnant women.

Design outcomes

Primary

Measure	Time frame
Relief in the symptoms of Amlapitta described below- Daha,Amlodgara,Shula,Chardi,Avipaka,AruchiTimepoint: 48 days	—

Secondary

Measure	Time frame
Relief in the symptoms of Amlapitta described below- Daha,Amlodgara,Shula,Chardi, Avipaka,AruchiTimepoint: 48 days	—

Countries

India

Contacts

Public ContactAstha Shukla

Uttarakhand Ayurveda university,Gurukul campus,Haridwar

dr.gdshukla@gmail.com8791265576

Outcome results